So, assuming 2% growth, Gilead is slightly undervalued. In fact, Gilead appears valued for 0% growth. Actually, this may be a ...

The FDA has placed a partial clinical fold on clinical trials of Gilead Sciences' magrolimab, the centre piece of its $4.9 billion acquisition of Forty Seven in 2020.

Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

November 25, 2024 • Books We Love returns with 350+ new titles handpicked by NPR staff and trusted critics. Find 12 years of recommendations all in one place — that's nearly 4,000 great reads ...

On this week's episode of The Debrief Weekly Report, Kenna and MJ chat about the subtle art of growing space structures with living organisms. They then chuck an asteroid at Earth to test the latest ...